Holen Sie sich die Stockscreener-App
1.415
2.16%
0.0299
Handel nachbörslich:
1.42
0.005
+0.35%
Schlusskurs vom Vortag:
$1.3851
Offen:
$1.4183
24-Stunden-Volumen:
3,320
Relative Volume:
0.09
Marktkapitalisierung:
$3.88M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-2.25M
KGV:
-3.5375
EPS:
-0.4
Netto-Cashflow:
-
1W Leistung:
+1.80%
1M Leistung:
-6.29%
6M Leistung:
-14.76%
1J Leistung:
-45.58%
1-Tages-Spanne:
$1.415
$1.47
1-Wochen-Bereich:
$1.32
$1.48
52-Wochen-Spanne:
$0.86
$2.9725
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile
Firmenname
X T L Biopharmaceuticals Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie XTLB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XTLB
X T L Biopharmaceuticals Ltd Adr
|
1.415 | 12.21M | 0 | -2.25M | 0 | -0.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2015-05-08 | Eingeleitet | H.C. Wainwright | Buy |
X T L Biopharmaceuticals Ltd Adr Aktie (XTLB) Neueste Nachrichten
XTL Biopharmaceuticals Approves Key Resolutions at Shareholder Meeting - TipRanks
XTL Biopharmaceuticals Postpones Shareholders’ Meeting Due to Quorum Issue - TipRanks
XTL Biopharmaceuticals Announces Shareholder Meeting for Key Decisions - TipRanks
XTL Biopharmaceuticals Appoints Noam Band as CEO - TipRanks
XTL Biopharmaceuticals Enters Sublicense Agreement with Biossil - TipRanks
XTL Biopharmaceuticals Adjusts Board Representation Amid Resignations - TipRanks
Form N-CSR FIDELITY CONCORD STREET For: Nov 30 - StreetInsider.com
XTL Biopharmaceuticals Reports Financial Results Amid Regional Unrest - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
XTL Biopharmaceuticals Expands with AI Company Acquisition - TipRanks
Finanzdaten der X T L Biopharmaceuticals Ltd Adr-Aktie (XTLB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):